Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | SC / LA |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | LA |
| FLU3 | INFLUENZA (SEASONAL) (FLUBLOK) | SANOFI PASTEUR | UNK | 49281-0725-10 | RA |
Body rash began 36 hours after vaccine; This is a spontaneous report received from a Consumer or other non HCP. A 64-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 23Sep2025 at 12:00 as dose 1, single (Batch/Lot number: unknown) at the age of 63 years, in left arm for covid-19 immunisation; influenza vaccine rha 3v (baculovirus) (FLUBLOK), on 23Sep2025 as dose number unknown, single (Lot number: 49281-0725-10), in right arm for immunisation. The patient's relevant medical history included: "Allergies: Penicillin" (unspecified if ongoing); "Allergies: Cipro" (unspecified if ongoing); "Allergies: Sulfa drugs" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: RASH (non-serious) with onset 25Sep2025 at 12:00, outcome "not recovered", described as "Body rash began 36 hours after vaccine". Therapeutic measures were not taken as a result of rash. Additional information: The patient did not received any other vaccines within 4 weeks PRIOR to the vaccine(s). The patient was not taking any other medications within 2 weeks of the event starting. The patient had no medical history. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Allergy to antibiotic; Penicillin allergy; Sulfonamide allergy